Previous Page  12 / 13 Next Page
Information
Show Menu
Previous Page 12 / 13 Next Page
Page Background

Page 36

Note:

allied

academies

Joint Event on

S e p t e m b e r 1 0 - 1 1 , 2 0 1 8 | D u b l i n , I r e l a n d

TOXICOLOGY AND PHARMACOLOGY

PHARMACEUTICAL CHEMISTRY & DRUG DISCOVERY

&

Global Congress on

International Conference on

Pharma Chem Congress 2018 & Toxicology Congress 2018 

Asian Journal of Biomedical and Pharmaceutical Sciences

|

Volume 8

Asian J Biomed Pharmaceut Sci 2018, Volume 8 | DOI: 10.4066/2249-622X-C2-006

RELATIONSHIP BETWEEN ON-SITE ORAL FLUID TESTING AND THC

PLASMA CONCENTRATIONS IN MARIJUANA SMOKERS

Simon N and Alvarez J C

Aix-Marseille University, France

T

he study aimwas to define the pharmacokinetic of delta-9-tetrahydrocannabinol (THC) and 11- OH-THC following two inhaled

doses of cannabis and to evaluate the relationship between THC plasma concentrations and on-site oral fluid screening de-

vice Drugwipe 5S

®

in chronic and occasional marijuana smokers, 30 healthy male volunteers: 15 regular (1-2 joints/day) and 15

occasional (1-2 joints/week) consumers aged 18-34 were included. Blood concentrations of THC were measured after controlled

inhalation of 10 mg or 30 mg. Blood samples were collected 5, 15, 30 minutes, 1, 2, 4, 6, 8, 10, 12 and 24 hours after the end of the

joint, and an oral fluid test was carried out at the same times up to six hours with a final test at 24 h before leaving the study. First,

a population PK analysis was performed using a non-linear mixed effects modelling. Then, the relationship between a positive

oral fluid testing and several covariates was evaluated using a logistic regression analysis. For THC, the best base model used

three-compartments with zero-order input and first-order output. The group had a significant effect on relative bioavailability

(F1). Chronic cannabis users had a 2.41 times greater value of F1 than the occasional users. Dose achieved to non-linearity with

a decrease by 0.68 of F1 for 30 mg compared to 10 mg. For 11-OH-THC, the model was a two-compartments with first-order

input. The logistic model describing the probability of a positive oral fluid testing included the THC plasma concentrations (es-

timate 246, IC95: 169-547) and the group (estimate -1.81, IC95: -3.09- -0.78) with an intercept of -1.20 (-2.36- -0.47). This study

described a non-linear relative bioavailability of THC with higher doses leading to a lower exposure. Further, with a same THC

concentration, users who smoke cannabis occasionally have a higher probability to be screened positive compared to daily users.